Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Red Biotechnology Market: By Application: Biopharmaceutical Production, Gene Therapy, Pharmacogenomics, Genetic Testing; By End Use: Pharmaceutical Industry, CMO & CRO, Research Institutes; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Red Biotechnology Market Outlook
The global red biotechnology market attained USD 320 billion in 2020 and is expected to grow at a CAGR of 6% during the forecast period of 2021-2026 to reach a value of USD 454 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
It is anticipated that the increasing awareness of chronic illness therapy and a strong pipeline of fresh therapeutic molecules will drive the global red biotechnology market.
Properties and Applications
Red biotechnology is a bio-pharmaceutical that involves the utilization of organisms to enhance health care and aid the body in fighting diseases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global red biotechnology market is segmented into applications and end-uses.
Based on applications, the red biotechnology market can be segmented as:
- Biopharmaceutical Production
- Gene Therapy
- Pharmacogenomics
- Genetic Testing
Based on end-uses, the red biotechnology market can be divided as:
- Pharmaceutical Industry
- CMO and CRO
- Research Institutes
- Others
The EMR report looks into the regional red biotechnology markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
Owing to the increasing demand for gene therapy, clinical research, and trials, the industry for red biotechnology is increasing. People have begun to preserve their stem cells at the moment of birth because of growing awareness, and red biotechnology makes an enormous profit in this segment. The red biotechnology market is aided by the growth of pharmaceutical companies. With the increasing number of patients suffering from cancer globally, red biotechnology applications are becoming common as it helps to understand the cause of the disease, thus, further aiding the growth of the red biotechnology market. The industry is being fuelled by the increased financing in the healthcare industry.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global red biotechnology industry, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Pfizer Inc. (NYSE: PFE)
- Biogen Inc.
- Amgen Inc.
- AstraZeneca Plc.
- Gilead Sciences, Inc.
- Celgene Corporation
- F. Hoffmann-La Roche, Ltd.
- Merck KGaA
- Regeneron Pharmaceuticals, Inc.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
Key Questions Answered in the Report
- How has the global red biotechnology market performed in the previous years (2016-2020)?
- What is the forecast assessment of the red biotechnology market for 2021-2026?
- What are the major drivers in the historical (2016-2020) and forecast (2021-2026) periods?
- What are the major constraints in the global red biotechnology market?
- What is the degree of competition in the global red biotechnology market?
- What are the major events and developments taking place within the industry globally?
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.1.1 Research Objective
1.1.2 Key Findings of the Report
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.4 Assumptions
2.5 Market Models
3 Introduction
3.1 Market Outlook
3.2 Market Scope and Segmentation
3.3 Additional Insights
4 Executive Summary
4.1 Key Market Developments
4.2 Market Analysis
4.3 Key Players
4.4 Market Revenue and Growth
5 Market Dynamics
5.1 Market Driver Analysis
5.2 Market Restraint Analysis
5.3 Industry Challenges
5.4 Industry Opportunities
6 Global Red Biotechnology Market Analysis
6.1 Global Red Biotechnology Historical Market (2016-2020) & Forecast (2021-2026)
6.2 Global Red Biotechnology Market Breakup by Application
6.2.1 Biopharmaceutical Production
6.2.2 Gene Therapy
6.2.3 Pharmacogenomics
6.2.4 Genetic Testing
6.3 Global Red Biotechnology Market Breakup by Application: Historical Market (2016-2020) & Forecast (2021-2026)
6.3.1 Biopharmaceutical Production
6.3.2 Gene Therapy
6.3.3 Pharmacogenomics
6.3.4 Genetic Testing
6.4 Global Red Biotechnology Market Breakup by End Use
6.4.1 Pharmaceutical Industry
6.4.2 CMO & CRO
6.4.3 Research Institutes
6.4.4 Others
6.5 Global Red Biotechnology Market Breakup by End Use: Historical Market (2016-2020) & Forecast (2021-2026)
6.5.1 Pharmaceutical Industry
6.5.2 CMO & CRO
6.5.3 Research Institutes
6.5.4 Others
6.6 Global Red Biotechnology Market Breakup by Region
6.6.1 North America
6.6.1.1 United States of America
6.6.1.2 Canada
6.6.2 Europe
6.6.2.1 Germany
6.6.2.2 United Kingdom
6.6.2.3 France
6.6.2.4 Italy
6.6.2.5 Others
6.6.3 Asia Pacific
6.6.3.1 China
6.6.3.2 Japan
6.6.3.3 India
6.6.3.4 ASEAN
6.6.3.5 Others
6.6.4 Latin America
6.6.4.1 Brazil
6.6.4.2 Argentina
6.6.4.3 Mexico
6.6.4.4 Others
6.6.5 Middle East & Africa
6.6.5.1 Saudi Arabia
6.6.5.2 United Arab Emirates
6.6.5.3 Nigeria
6.6.5.4 South Africa
6.6.5.5 Others
6.7 Global Red Biotechnology Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
6.7.1 North America
6.7.1.1 United States of America
6.7.1.2 Canada
6.7.2 Europe
6.7.2.1 Germany
6.7.2.2 United Kingdom
6.7.2.3 France
6.7.2.4 Italy
6.7.2.5 Others
6.7.3 Asia Pacific
6.7.3.1 China
6.7.3.2 Japan
6.7.3.3 India
6.7.3.4 ASEAN
6.7.3.5 Others
6.7.4 Latin America
6.7.4.1 Brazil
6.7.4.2 Argentina
6.7.4.3 Mexico
6.7.4.4 Others
6.7.5 Middle East & Africa
6.7.5.1 Saudi Arabia
6.7.5.2 United Arab Emirates
6.7.5.3 Nigeria
6.7.5.4 South Africa
6.7.5.5 Others
7 SWOT Analysis
7.1 Overview
7.2 Strengths
7.3 Weaknesses
7.4 Opportunities
7.5 Threats
8 Porter’s Five Forces Analysis
8.1 Overview
8.2 Buyer’s Power
8.3 Supplier’s Power
8.4 New Entrants
8.5 Degree of Rivalry
8.6 Substitutes
9 Competitive Landscape & Supplier Analysis
9.1 Pfizer Inc. (NYSE: PFE)
9.1.1 Company Overview
9.1.2 Financial Analysis
9.2 Biogen Inc. (NASDAQ: BIIB)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.3 Amgen Inc. (NASDAQ: AMGN)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.4 AstraZeneca Plc. (LON: AZN)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 Gilead Sciences, Inc. (NASDAQ: GILD)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.6 Celgene Corporation (NASDAQ: CELG)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.7 F. Hoffmann-La Roche, Ltd. (SWX: ROG)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.8 Merck KGaA (ETR: MRK)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.9 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)
9.9.1 Company Overview
9.9.2 Financial Analysis
9.10 Others
10 Industry Events and Developments
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
Orthobiologics Market Size, Share, Price, Trends, Report 2021-2026
Human Augmentation Market Size, Share, Report and Forecast 2021-2026
Bio-Process Technology Market Size, Share, Industry, Report 2021-2026
The global neurotechnology market reached a value of about USD 10.7 billion in 2020. The industry is further expected to grow at a CAGR of 12% in the forecast period of 2021-2026 to reach a value of a...
The global artificial organs market attained a value of USD 15.3 billion in 2020, driven by the rising demand for organ transplantation. Aided by the growing advancements in the field of 3D bioprintin...
NEWSLETTER